Nephrocare Health Services IPO
Nephrocare Health Services IPO — date, price band, GMP & allotment 2025
Nephrocare Health Services is a specialized dialysis care provider operating the NephroPlus network with more than 519 clinics across India and abroad (including Philippines, Uzbekistan, Nepal). The company delivers comprehensive renal care services such as in-clinic haemodialysis, mobile and home dialysis, wellness programmes, and pharmacy support. It serves a significant share of dialysis patients and aims to expand its clinic footprint in Indiprovider)
Stock price
Nephrocare Health Services is listed — here is the live share price.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Timetable
Key dates from opening to listing. Today is 14 September.
- Open 10 Dec 2025
- Close 12 Dec 2025
- Allotment 15 Dec 2025
- Refund/credit 16 Dec 2025
- Listing 17 Dec 2025
Issue summary
The terms of the offer, as filed.
| IPO Dates | 10 to 12 Dec, 2025 |
|---|---|
| Price Band | ₹438 – 460 |
| Face Value | ₹2 |
| Lot Size | 32 Shares |
| Issue Size | ₹871.05 Cr |
| Sale Type | Fresh capital cum OFS |
| Listing On | BSE & NSE |
| Employee Discount | NA |
| Registrar | KFin Technologies Limited |
| Min Investment | ₹ 14,720 |
Share of the offer set aside for each investor category, as stated in the offer document.
What will it cost me?
Bidding is in multiples of 32 shares at the ₹460 cut-off. Drag to size your application.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 32 | ₹14,720 |
| Retail (max) | 13 | 416 | ₹1,91,360 |
| S-HNI (min) | 14 | 448 | ₹2,06,080 |
| S-HNI (max) | 67 | 2,144 | ₹9,86,240 |
| B-HNI (min) | 68 | 2,176 | ₹10,00,960 |
Three years of numbers
All figures in ₹ crore, as reported in the Nephrocare Health Services offer document.
| Metric | 30 Mar 25 | 31 Mar 24 | 31 Mar 24 |
|---|---|---|---|
| Revenue | 483.97 | 769.92 | 574.72 |
| EBITDA | 110.31 | 166.64 | 99.66 |
| Net Profit | 14.23 | 67.10 | 35.13 |
| Debt | 207.04 | 225.80 | 243.37 |
| Assets | 1,193.68 | 996.46 | 806.02 |
See how this IPO compares — view listing performance of all mainboard IPOs.
Valuation & key ratios
Ratios are for the latest full financial year reported in the Nephrocare Health Services RHP. EPS and P/E are post-issue — the table below carries the pre-issue comparison.
Nephrocare Health Services IPO Valuation
How the issue prices the company before and after the fresh shares are created.
| Valuation Metric | Post-Issue |
|---|---|
| EPS (₹) | ₹2.84 |
| P/E Ratio (x) | 162.19 |
| Market Cap at Offer Price (₹ Cr) | ₹2,304.86 |
Pre-issue figures use the shareholding reported in the RHP; post-issue figures use the shareholding once the fresh issue has created new shares. The two differ because of that dilution and because post-issue earnings per share are often annualised, so the change can run in either direction. Market capitalisation is calculated at the ₹460 offer price. Compare the post-issue P/E against listed peers before deciding — a premium there is growth you are paying for in advance.
Where the money goes
How the company intends to use the proceeds of the issue.
About the company
The company primarily offers dialysis services, including haemodialysis and related renal care treatments, supported by trained medical staff and modern equipment. Its business model is asset-light and partnership-driven, where it collaborates with hospitals to operate dialysis centres within their premises, reducing capital expenditure while expanding reach. Revenue is generated through long-term service agreements and patient volumes. Promoted by professionals with domain expertise, Nephrocare focuses on operational efficiency, affordability, and scalability, aiming to address the rising demand for kidney care services in both urban and semi-urban regions.
Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.
+91 40 4240 8039
The bankers & the filings
Who is running the book, and the documents this page is built from.
Nephrocare Health Services IPO Documents
Read the filings this page is built from.
Lead Manager Track Record
How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.
ICICI Securities
22 issues handledBest listing: Tempsens Instruments (India) (+111.3%). Weakest: Turtlemint Fintech Solutions (-10.4%).
Ambit Capital
1 issue handled1 of their issues has listed so far, and 0 opened above the issue price (average 0%). That is too small a sample to read as a hit rate.
IIFL Capital Services Limited
25 issues handledBest listing: Corona Remedies (+38.4%). Weakest: Purple Style Labs (-7.0%).
Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.
Company contact
Frequently asked
What is the GMP of Nephrocare Health Services?
The current Grey Market Premium is ₹0.
What is the Nephrocare Health Services IPO price band?
₹438 to ₹460, on a face value of ₹2.
When is the allotment?
The basis of allotment is 15 December 2025, with listing on 17 December 2025.
How do I check allotment status?
On the IPO Guru allotment page or on the registrar's site — KFin Technologies Limited.
Every number here traces back to a filing.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Every number on this page is sourced from the RHP, BSE & NSE.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
